Idiopathic anaphylaxis due to SARS-CoV-2 mRNA vaccine?
Main Article Content
Keywords
Idiopathic anaphylaxis, chronic urticaria, COVID-19, mRNA vaccination
Abstract
N/A
References
1 Korkmaz P, Demir S, Karabacak DE, Unal D, Gelincik A. A case with recurrent idiopathic anaphylaxis episodes starting soon after COVID-19 mRNA vaccination. Allergol Immunopathol (Madr). 2024;52(6):58–61.
2 Özdemir Ö. Chronic urticaria following COVID-19 mRNA vaccines. JAAD Case Rep. 2024;49:77–78. 10.1016/j.jdcr.2024.04.041
3 Özdemir Ö. Might chronic spontaneous urticaria develop after SARS-CoV-2 vaccinations? Eur J Clin Pharmacol. 2023;79(9):1279–80. 10.1007/s00228-023-03532-1
4 Özdemir Ö, Dikici Ü, Kibar BS. Chronic spontaneous urticaria patient developing idiopathic anaphylaxis and responding to omalizumab treatment: case Report. Asthma Allergy Immunol 2023;21:237–40.
5 Boxer M, Greenberger PA, Patterson R. Clinical summary and course of idiopathic anaphylaxis in 73 patients. Arch Intern Med. 1987;147(2):269–72.
6 Singh GK. Omalizumab, a savior in long term prevention of idiopathic anaphylaxis with urticaria: a case series. Dermatol Ther. 2021;34(6):e15165. 10.1111/dth.15165
7 Özdemir Ö, Bozkurt HB, Elmas B. Omalizumab’s role in the treatment of steroid-dependent malignant idiopathic anaphylaxis. Turk Pediatri Ars. 2017;52(2):105–7. 10.5152/TurkPediatriArs.2017.2262
8 Hide M, Kaplan AP. Concise update on the pathogenesis of chronic spontaneous urticaria (CSU). J Allergy Clin Immunol. 2022;150(6):1403–4. 10.1016/j.jaci.2022.08.022
9 Maronese CA, Ferrucci SM, Moltrasio C, Lorini M, Carbonelli V, Asero R, et al. IgG and IgE autoantibodies to IgE receptors in chronic spontaneous urticaria and their role in the response to omalizumab. J Clin Med. 2023;12(1):378. 10.3390/jcm12010378
10 Larenas-Linnemann D. Biomarkers of autoimmune chronic spontaneous urticaria. Curr Allergy Asthma Rep. 2023; 23(12):655–64. 10.1007/s11882-023-01117-7
2 Özdemir Ö. Chronic urticaria following COVID-19 mRNA vaccines. JAAD Case Rep. 2024;49:77–78. 10.1016/j.jdcr.2024.04.041
3 Özdemir Ö. Might chronic spontaneous urticaria develop after SARS-CoV-2 vaccinations? Eur J Clin Pharmacol. 2023;79(9):1279–80. 10.1007/s00228-023-03532-1
4 Özdemir Ö, Dikici Ü, Kibar BS. Chronic spontaneous urticaria patient developing idiopathic anaphylaxis and responding to omalizumab treatment: case Report. Asthma Allergy Immunol 2023;21:237–40.
5 Boxer M, Greenberger PA, Patterson R. Clinical summary and course of idiopathic anaphylaxis in 73 patients. Arch Intern Med. 1987;147(2):269–72.
6 Singh GK. Omalizumab, a savior in long term prevention of idiopathic anaphylaxis with urticaria: a case series. Dermatol Ther. 2021;34(6):e15165. 10.1111/dth.15165
7 Özdemir Ö, Bozkurt HB, Elmas B. Omalizumab’s role in the treatment of steroid-dependent malignant idiopathic anaphylaxis. Turk Pediatri Ars. 2017;52(2):105–7. 10.5152/TurkPediatriArs.2017.2262
8 Hide M, Kaplan AP. Concise update on the pathogenesis of chronic spontaneous urticaria (CSU). J Allergy Clin Immunol. 2022;150(6):1403–4. 10.1016/j.jaci.2022.08.022
9 Maronese CA, Ferrucci SM, Moltrasio C, Lorini M, Carbonelli V, Asero R, et al. IgG and IgE autoantibodies to IgE receptors in chronic spontaneous urticaria and their role in the response to omalizumab. J Clin Med. 2023;12(1):378. 10.3390/jcm12010378
10 Larenas-Linnemann D. Biomarkers of autoimmune chronic spontaneous urticaria. Curr Allergy Asthma Rep. 2023; 23(12):655–64. 10.1007/s11882-023-01117-7
Article Sidebar
Published
Mar 1, 2025
Article Details
How to Cite
Özdemir, Öner. (2025). Idiopathic anaphylaxis due to SARS-CoV-2 mRNA vaccine?. Allergologia Et Immunopathologia, 53(2), 8-9. https://doi.org/10.15586/aei.v53i2.1299
Section
Letter to Editor
How to Cite
Özdemir, Öner. (2025). Idiopathic anaphylaxis due to SARS-CoV-2 mRNA vaccine?. Allergologia Et Immunopathologia, 53(2), 8-9. https://doi.org/10.15586/aei.v53i2.1299